475596-40-8

Basic information

• Product Name: methyl 2-methoxy-5-[3-(4-(5-phenylpentyloxy)phenyl)propanoylamino]benzoate
• Synonyms: methyl 2-methoxy-5-[3-(4-(5-phenylpentyloxy)phenyl)propanoylamino]benzoate
• CAS NO: 475596-40-8
• Molecular Weight: 475.585
• Mol File: 475596-40-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 2-methoxy-5-[3-(4-(5-phenylpentyloxy)phenyl)propanoylamino]benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-methoxy-5-[3-(4-(5-phenylpentyloxy)phenyl)propanoylamino]benzoate(475596-40-8)
• EPA Substance Registry System: methyl 2-methoxy-5-[3-(4-(5-phenylpentyloxy)phenyl)propanoylamino]benzoate(475596-40-8)

Safety Data

• Hazardous Substances Data: 475596-40-8(Hazardous Substances Data)

Upstream product

• 5597-50-2 3-(4-hydroxyphenyl)propionic acid methyl ester 
• 10521-91-2 5-phenylpentan-1-ol 
• 273939-77-8 methyl 3-[4-(5-phenylpentyloxy)phenyl]propanoate 
• 475597-80-9 3-[4-(5-phenylpentyloxy)phenyl]propanoyl chloride 
• 22802-67-1 methyl 2-methoxy-5-aminobenzoate 

Relevant articles and documents

CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT

Compounds represented by formula (I), prodrugs thereof and salts thereof, and pharmaceutical compositions comprising the same as an active ingredient (wherein each symbol has the meaning as defined in the soecification.). Because of having an EDG-1 agonism, the compounds represented by formula (I) are useful in preventing and /or treating peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid, anal fissure or fistula ani, dissecting aneurysm of the aorta, angina, DIC, pleuritis, congestive heart failure, multiple organ failure, bedsore, burn, chronic ulcerative colitis, Crohn's disease, heart transplantation, renal transplantation, dermal graft, liver transplantation, osteoporosis, pulmonary fibrosis, interstitial pneumonia, chronic hepatitis, liver cirrhosis, chronic renal failure, or glomerular sclerosis.